Poseida Therapeutics (PSTX) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.65
-0.13
0.4
0.92

Details

Expected EPS
-0.53
Actual EPS
-0.32
Surprise EPS
0.21
Surprise Percent
+39.62%

Description

Poseida Therapeutics (PSTX) has reported earnings of -0.32 per share for Q2 2023.

0 Comments

Share your thoughts